1Wellinghausen,N,Straube E,Freidank H,et al.Low Prevalence of Chlamydia pneumoniae in adults with community-acquired pneumonia.Int J Med Microbiol,2006;296:485-91
8Lee WK,(&) Young BW.Antibiotics for childhood community-acquired pneumonia in a region with a high prevalence of penicillin non-susceptible Streptococcus pneumoniae.J Antimicrob Chemother,2005;556:603-5
10Miyashita,N.Saito.A,Kohno.S et al.Multiplex PCR for the simultaneous detection of Chlamydia pneumoniae,Mycoplasma pneumoniae and Legionella pneumophial in community-acquired pneumonia.Respir Med,2004;98:542-50
7Ngeow YF,Suwanjutha S,Chantarojanasriri T,et al.An asian study on the prevalence of atypical respiratory pathogens in community-acquired pneumonia.Int J Infect Dis,2005,9:144-153.
8Lepow ML,Balassanian N,Emmerich J,et al.Interrelationships of viral,mycoplasmal,and bacterial agents in uncomplicated pneumonia.Am Rev Respir Dis,1968,97:533-545.
9Lim WS,Macfarlane JT,Boswell TC,et al.Study of community acquired pneumonia aetiology(SCAPA) in adults admitted to hospital:implications for management guidelines.Thorax,2001,56:296-301.
10Niederman MS,Mandell LA,Anzueto A,et al.Guidelines for the management of adults with community-acquired pneumonia.Diagnosis,assessment of severity,antimicrobial therapy,and prevention.Am J Respir Crit Care Med,2001,163:1730-1754.
